1 min to read News Posted on January 12, 2023 Will 2023 be the year that pharma M&A makes a comeback? – MarketWatch Will 2023 be the year that pharma M&A makes a comeback? MarketWatch Source: Will 2023 be the year that pharma M&A makes a comeback? – MarketWatch share tweet share Why Buy a SPAC Before It Identifies a Target?SPAC Promoters Lost $1B+ in 2022, and There’s More Pain to Come – 24/7 Wall St.By the Numbers: Four Practices Big Law Firms Need to Power 2023 – Bloomberg LawSPACs: Are You Really Ready To Commit? Tags: SPACs